West Pharmaceutical Services (WST) Raw Materials (2010 - 2012)

West Pharmaceutical Services has disclosed Raw Materials across 3 years of filings, most recently posting $68.6 million for Q2 2012.

• Raw Materials for Q2 2012 came in at $68.6 million, up 4.41% year-over-year; the trailing twelve-month figure through Jun 2012 was $68.6 million (up 4.41% YoY), and the FY2011 annual result was $65.1 million, up 7.6% from the prior year.
• Raw Materials came in at $68.6 million for Q2 2012 at West Pharmaceutical Services, up from $65.1 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $68.6 million in Q2 2012 to a low of $60.5 million in Q4 2010.
• The 3-year median for Raw Materials is $65.1 million (2011), against an average of $65.0 million.
• Across the five-year window, Raw Materials rose 7.6% in 2011 and increased 4.41% in 2012, its largest moves.
• West Pharmaceutical Services' Raw Materials stood at $60.5 million in 2010, then increased by 7.6% to $65.1 million in 2011, then increased by 5.38% to $68.6 million in 2012.
• The last three Raw Materials figures came in at $68.6 million (Q2 2012), $65.1 million (Q4 2011), and $64.9 million (Q3 2011), per Business Quant data.